Development and Application of an LC-MS/MS Method for Simultaneous Quantification of Azathioprine and Its Metabolites: Pharmacokinetic and Microbial Metabolism Study of a Colon-Targeted Nanoparticle
Open Access
- 26 December 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (1) , 58
Abstract
Background/Objectives: Given the clinical limitations of azathioprine (AZA) in treating inflammatory bowel disease, this study developed an AZA-loaded microbiota-modulating and colon-targeted nanoparticle constructed from pectin, Zein, and Eudragit®S100 (APZE), which was hypothesized to enhance efficacy while reducing toxicity. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was established to simultaneously quantify AZA and its metabolites, enabling the investigation of the pharmacokinetic and microbial metabolism differences between APZE and AZA suspension (AZAS). Methods: APZE was characterized, and an LC-MS/MS method was developed for quantifying AZA and its metabolites in multiple matrices. Given the potential of APZE for colon targeting and modulation of the microbiota, which may affect drug absorption, distribution, and microbiota-mediated metabolism, we determined analyte concentrations in rat plasma, tissues, and microbial cultures at different time points following administration of APZE or AZAS. Results: AZA, 6-mercaptopurine (6-MP), 6-methylmercaptopurine (6-MMP), and 6-thioguanine (6-TG) were quantified in positive ion mode, and 6-thiouric acid (6-TU) in negative ion mode. The assay demonstrated excellent accuracy, precision, and stability over the concentration range of 5–1000 ng/mL. Orally administered APZE exhibited higher bioavailability, improved intestinal absorption, and reduced formation of the inactive metabolite 6-TU compared to AZAS. In microbial cultures, AZA was metabolized primarily to 6-MP, and APZE underwent more extensive metabolism to 6-MP than AZAS. Conclusions: This method provides accurate and precise quantification of physiologically relevant concentrations of AZA and its metabolites (6-MP, 6-MMP, 6-TG, and 6-TU), offering a bioanalytical tool for the pharmacokinetic and gut microbiota metabolism studies of AZA formulations. These findings suggest that APZE is a promising drug delivery formulation.Keywords
Funding Information
- National Natural Science Foundation of China (82173894)
- Beijing Natural Science Foundation of China (7232246)
- Beijing Natural Science Foundation of China (L202042)
- National Key Research and Development Program of China (2023YFC2706100)
This publication has 32 references indexed in Scilit:
- Zein: Potential biopolymer in inflammatory bowel diseasesJournal of Biomedical Materials Research Part A, 2024
- Potential mechanisms of different methylation degrees of pectin driving intestinal microbiota and their metabolites to modulate intestinal health of Micropterus salmoidesInternational Journal of Biological Macromolecules, 2023
- Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experienceJGH Open, 2023
- Development and validation of a novel HPLC-UV method for simultaneous determination of azathioprine metabolites in human red blood cellsHeliyon, 2023
- Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterologyBest Practice & Research Clinical Gastroenterology, 2021
- Determination of 6-thioguanine and 6-methylmercaptopurine in dried blood spots using liquid chromatography-tandem mass spectrometry: Method development, validation and clinical applicationClinica Chimica Acta, 2019
- Magnetic molecularly imprinted polymer nanoparticles for simultaneous extraction and determination of 6-mercaptopurine and its active metabolite thioguanine in human plasmaJournal of Chromatography A, 2018
- Bioanalytical method development and validation: Critical concepts and strategiesJournal of Chromatography B, 2017
- Development and validation of LC–MS/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: Correlation with genetic polymorphismJournal of Chromatography B, 2016
- Development and validation of an HPLC method for the rapid and simultaneous determination of 6-mercaptopurine and four of its metabolites in plasma and red blood cellsJournal of Pharmaceutical and Biomedical Analysis, 2009